NeoImmuneTech, Inc. (KOSDAQ:950220)
South Korea · Delayed Price · Currency is KRW 468.00
-4.00 (-0.85%)
Apr 30, 2026, 3:30 PM KST
NeoImmuneTech Market Cap
NeoImmuneTech has a market cap or net worth of 46.27 billion as of April 30, 2026. Its market cap has decreased by -57.80% in one year.
Market Cap
46.27B
Enterprise Value
-4.06B
Revenue
94.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
468.00
Market Cap Chart
Since March 16, 2021, NeoImmuneTech's market cap has decreased from 1.46T to 46.27B, a decrease of -96.84%. That is a compound annual growth rate of -49.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 46.67B | -42.51% |
| Dec 30, 2025 | 81.17B | -27.02% |
| Dec 30, 2024 | 111.23B | -44.44% |
| Dec 28, 2023 | 200.21B | -49.29% |
| Dec 29, 2022 | 394.82B | -61.23% |
| Dec 30, 2021 | 1.02T | -30.48% |
| Mar 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Macrogen | 184.85B |
| Vaxcell-Bio Therapeutics | 182.57B |
| ENCell | 181.64B |
| Amicogen | 134.78B |
| iNtRON Biotechnology | 122.98B |
| Oncocross | 107.81B |
| CG Invites | 101.50B |
| IMB Dx | 101.21B |